Settling the Score With Cardiac Amyloidosis
- PMID: 37589608
- DOI: 10.1016/j.jcmg.2023.06.013
Settling the Score With Cardiac Amyloidosis
Keywords: cardiac amyloidosis; risk score; transthyretin cardiac amyloidosis.
Conflict of interest statement
Funding Support and Author Disclosures Dr Hanna served on Advisory Boards for Pfizer, Alnylam, Ionis, Eidos, and Alexion Pharmaceuticals. Dr Rosenthal served on the Advisory Boards for Pfizer and Alnylam; and her institution has received research clinical trial funding from Alnylam and Akcea.
Comment on
-
Development and Validation of a Prediction Model and Score for Transthyretin Cardiac Amyloidosis Diagnosis: T-Amylo.JACC Cardiovasc Imaging. 2023 Dec;16(12):1567-1580. doi: 10.1016/j.jcmg.2023.05.002. Epub 2023 Jun 28. JACC Cardiovasc Imaging. 2023. PMID: 37389511
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
